ASR UNI FEMORAL IMPL SIZE 49
Report
- Report Number
- 1818910-2013-04469
- Event Type
- Injury
- Date Received
- June 21, 2013
- Report Date
- August 29, 2011
- Manufacturer
- DEPUY INTERNATIONAL
- Product Code
- KWA
- PMA / PMN Number
- K040627
- Removal / Correction Number
- Z-1749/1816-2011
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- ATTORNEY
Narratives
THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.
DEPUY STILL CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.
LITIGATION PAPERS ALLEGE THE FOLLOWING: PATIENT EXPERIENCES EXCRUCIATING PAIN EVERY MINUTE OF THE DAY. CURRENTLY PATIENT IS FORCED TO TAKE PAIN MEDICATION INCLUDING MORPHINE EVERY SIX HOURS AS A RESULT IS CONSTANTLY DROWSY AND DYSFUNCTIONAL. BASED ON THESE CONDITIONS, PATIENTS DOCTORS WOULD RECOMMEND THAT HIS ASR HIP SYSTEM BE REVISED AND A NEW SYSTEM IMPLANTED. HOWEVER, GIVEN PATIENT'S HEART CONDITION, HIS DOCTORS HAVE CONCLUDED THAT HIP REVISION SURGERY WOULD POTENTIALLY KILL HIM AND HAVE THEREFORE ADVISED HIM HE MUST SIMPLY LIVE WITH THE EXCRUCIATING PAIN HE EXPERIENCES DAILY FOR THE REST OF HIS LIFE.
UPDATE: 01/30/2017¿ SALES REP HAS REPORTED A REVISION DUE TO PAIN. ADDING THE SLEEVE TO THE COMPLAINT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 282221 | ASR UNI FEMORAL IMPL SIZE 49 | FEMORAL HEAD HIP IMPLANT | KWA | DEPUY INTERNATIONAL | 2616104 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |